(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC1A2 mRNA] CTD PMID:31150632 (4-chloro-2-methylphenoxy)acetic acid affects expression EXP 6480464 2-Methyl-4-chlorophenoxyacetic Acid affects the expression of SLC1A2 protein CTD PMID:16019039 1,2-dichloroethane decreases expression ISO RGD:736773 6480464 ethylene dichloride results in decreased expression of SLC1A2 mRNA CTD PMID:28189721 , PMID:28960355 17alpha-ethynylestradiol increases expression ISO RGD:736773 6480464 Ethinyl Estradiol results in increased expression of SLC1A2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLC1A2 mRNA CTD PMID:29097150 17alpha-ethynylestradiol multiple interactions ISO RGD:736773 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC1A2 mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC1A2 protein CTD PMID:22645130 17beta-estradiol multiple interactions ISO RGD:736773 6480464 Estradiol inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA], Estradiol inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 protein] CTD PMID:29183790 17beta-estradiol decreases expression ISO RGD:732300 6480464 Estradiol results in decreased expression of SLC1A2 mRNA CTD PMID:20106945 , PMID:21632981 17beta-estradiol multiple interactions EXP 6480464 Pertussis Toxin inhibits the reaction [Estradiol results in increased expression of SLC1A2 protein] CTD PMID:22645130 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736773 6480464 [Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of SLC1A2 mRNA more ... CTD PMID:15251184 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 protein] more ... CTD PMID:26988466 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732300 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736773 6480464 Tetrachlorodibenzodioxin affects the expression of SLC1A2 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732300 6480464 Tetrachlorodibenzodioxin affects the expression of SLC1A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732300 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC1A2 mRNA CTD PMID:21998131 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 mRNA, Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 protein CTD PMID:21215274 , PMID:26988466 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC1A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736773 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC1A2 mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:732300 6480464 2 more ... CTD PMID:17547211 2-chloroethanol decreases expression EXP 6480464 Ethylene Chlorohydrin results in decreased expression of SLC1A2 protein CTD PMID:27596522 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:736773 6480464 3 more ... CTD PMID:19467301 3,3',5-triiodo-L-thyronine increases expression ISO RGD:736773 6480464 Triiodothyronine results in increased expression of SLC1A2 mRNA CTD PMID:25172293 3-phenylprop-2-enal increases expression ISO RGD:732300 6480464 cinnamaldehyde results in increased expression of SLC1A2 mRNA CTD PMID:19524605 4,4'-sulfonyldiphenol decreases expression ISO RGD:736773 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of SLC1A2 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO RGD:736773 6480464 Decitabine results in increased expression of SLC1A2 mRNA CTD PMID:15251184 5-aza-2'-deoxycytidine multiple interactions ISO RGD:736773 6480464 [Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of SLC1A2 mRNA CTD PMID:15251184 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC1A2 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC1A2 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:732300 6480464 Aflatoxin B1 results in increased expression of SLC1A2 mRNA CTD PMID:21641981 aflatoxin B1 decreases methylation ISO RGD:732300 6480464 Aflatoxin B1 results in decreased methylation of SLC1A2 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:732300 6480464 Tretinoin results in decreased expression of SLC1A2 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:732300 6480464 Tretinoin results in increased expression of SLC1A2 mRNA CTD PMID:23724009 all-trans-retinol multiple interactions ISO RGD:732300 6480464 Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein] CTD PMID:17138558 all-trans-retinol increases expression ISO RGD:736773 6480464 Vitamin A results in increased expression of SLC1A2 protein CTD PMID:17138558 all-trans-retinol increases expression ISO RGD:732300 6480464 Vitamin A results in increased expression of SLC1A2 protein CTD PMID:17138558 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC1A2 mRNA CTD PMID:16483693 ampicillin increases expression ISO RGD:732300 6480464 Ampicillin results in increased expression of SLC1A2 protein CTD PMID:17138558 antimycin A decreases expression ISO RGD:732300 6480464 Antimycin A results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO RGD:732300 6480464 Antirheumatic Agents results in decreased expression of SLC1A2 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC1A2 mRNA, Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC1A2 protein CTD PMID:22627295 arsenous acid decreases expression ISO RGD:732300 6480464 Arsenic Trioxide results in decreased expression of SLC1A2 mRNA CTD PMID:17547211 atorvastatin calcium multiple interactions ISO RGD:736773 6480464 Atorvastatin inhibits the reaction [APP protein results in decreased expression of SLC1A2 protein] CTD PMID:20816828 azoxystrobin decreases expression ISO RGD:732300 6480464 azoxystrobin results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO RGD:732300 6480464 Benzo(a)pyrene results in decreased expression of SLC1A2 mRNA CTD PMID:22316170 , PMID:26238291 benzo[a]pyrene increases methylation ISO RGD:732300 6480464 Benzo(a)pyrene results in increased methylation of SLC1A2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:732300 6480464 Benzo(a)pyrene affects the methylation of SLC1A2 3' UTR CTD PMID:27901495 Benzo[k]fluoranthene increases expression ISO RGD:736773 6480464 benzo(k)fluoranthene results in increased expression of SLC1A2 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide increases expression ISO RGD:736773 6480464 Mustard Gas results in increased expression of SLC1A2 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:732300 6480464 Diethylhexyl Phthalate results in decreased expression of SLC1A2 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC1A2 mRNA CTD PMID:29097150 bisphenol A decreases expression ISO RGD:732300 6480464 bisphenol A results in decreased expression of SLC1A2 protein CTD PMID:32363662 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC1A2 mRNA CTD PMID:27571134 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC1A2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC1A2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A2 mRNA CTD PMID:25607892 bisphenol A decreases expression ISO RGD:736773 6480464 bisphenol A results in decreased expression of SLC1A2 mRNA CTD PMID:26063408 bisphenol F decreases expression ISO RGD:736773 6480464 bisphenol F results in decreased expression of SLC1A2 mRNA CTD PMID:30951980 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of SLC1A2 mRNA CTD PMID:15808516 buta-1,3-diene decreases expression ISO RGD:736773 6480464 1, 3-butadiene results in decreased expression of SLC1A2 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:732300 6480464 butyraldehyde results in increased expression of SLC1A2 mRNA CTD PMID:26079696 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A2 mRNA CTD PMID:25607892 butyric acid multiple interactions EXP 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] CTD PMID:24469401 butyric acid multiple interactions ISO RGD:736773 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA], Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 protein] CTD PMID:28610743 cannabidiol decreases expression ISO RGD:736773 6480464 Cannabidiol results in decreased expression of SLC1A2 mRNA CTD PMID:33019509 cannabigerol decreases expression ISO RGD:736773 6480464 cannabigerol results in decreased expression of SLC1A2 mRNA CTD PMID:33019509 carbon nanotube decreases expression ISO RGD:736773 6480464 Nanotubes, Carbon results in decreased expression of SLC1A2 mRNA CTD PMID:25620056 ceftriaxone multiple interactions EXP 6480464 Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein] more ... CTD PMID:19717140 more ... ceftriaxone increases expression EXP 6480464 Ceftriaxone results in increased expression of SLC1A2 protein CTD PMID:19625514 more ... chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of SLC1A2 mRNA CTD PMID:17452286 chlorpyrifos multiple interactions ISO RGD:736773 6480464 [Chlorpyrifos co-treated with NGF protein] results in increased expression of SLC1A2 mRNA CTD PMID:20600679 cisplatin decreases response to substance ISO RGD:732300 6480464 SLC1A2 gene mutant form results in decreased susceptibility to Cisplatin CTD PMID:21471434 clofibrate decreases expression ISO RGD:736773 6480464 Clofibrate results in decreased expression of SLC1A2 mRNA CTD PMID:23811191 clozapine decreases activity EXP 6480464 Clozapine results in decreased activity of SLC1A2 protein CTD PMID:11443521 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of SLC1A2 mRNA, Clozapine results in decreased expression of SLC1A2 protein CTD PMID:11443521 , PMID:12873733 cobalt atom multiple interactions ISO RGD:732300 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of SLC1A2 mRNA CTD PMID:18078969 cobalt dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SLC1A2 protein] more ... CTD PMID:22895544 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of SLC1A2 mRNA, cobaltous chloride results in decreased expression of SLC1A2 protein CTD PMID:22895544 , PMID:24386269 cocaine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein], Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein] CTD PMID:19717140 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of SLC1A2 protein CTD PMID:19717140 copper(II) sulfate decreases expression ISO RGD:732300 6480464 Copper Sulfate results in decreased expression of SLC1A2 mRNA CTD PMID:19549813 corticosterone multiple interactions ISO RGD:732300 6480464 Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein], Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein] CTD PMID:17138558 corticosterone increases expression ISO RGD:736773 6480464 Corticosterone results in increased expression of SLC1A2 protein CTD PMID:17138558 corticosterone increases expression ISO RGD:732300 6480464 Corticosterone results in increased expression of SLC1A2 protein CTD PMID:17138558 coumarin increases expression EXP 6480464 coumarin results in increased expression of SLC1A2 mRNA CTD PMID:18480146 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC1A2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:732300 6480464 Cyclosporine results in decreased expression of SLC1A2 mRNA CTD PMID:25562108 DDE multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 deguelin decreases expression ISO RGD:732300 6480464 deguelin results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:736773 6480464 [Dexamethasone co-treated with INS protein co-treated with PRL protein] results in increased expression of SLC1A2 mRNA CTD PMID:28174119 dextran sulfate multiple interactions ISO RGD:736773 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC1A2 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:732300 6480464 Arsenic Trioxide results in decreased expression of SLC1A2 mRNA CTD PMID:17547211 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of SLC1A2 mRNA CTD PMID:17452286 dibutyl phthalate multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 dioxygen affects expression EXP 6480464 Oxygen deficiency affects the expression of SLC1A2 protein CTD PMID:15927375 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein more ... CTD PMID:25727173 , PMID:29045497 dorsomorphin multiple interactions ISO RGD:732300 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732300 6480464 Doxorubicin results in decreased expression of SLC1A2 mRNA CTD PMID:29803840 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A2 mRNA CTD PMID:25607892 epoxiconazole multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 ethanol multiple interactions EXP 6480464 N-methyl-N-(6-methoxy-1-phenyl-1 more ... CTD PMID:20655511 ethanol multiple interactions ISO RGD:736773 6480464 Ethanol affects the expression of and affects the splicing of SLC1A2 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:736773 6480464 Ethanol results in increased expression of SLC1A2 mRNA CTD PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SLC1A2 mRNA CTD PMID:20655511 folic acid decreases expression ISO RGD:736773 6480464 Folic Acid results in decreased expression of SLC1A2 mRNA CTD PMID:25629700 folpet decreases expression ISO RGD:736773 6480464 folpet results in decreased expression of SLC1A2 mRNA CTD PMID:31558096 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [4 more ... CTD PMID:24782323 fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of SLC1A2 protein CTD PMID:24782323 furan decreases expression EXP 6480464 furan results in decreased expression of SLC1A2 mRNA CTD PMID:25539665 , PMID:26194646 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of SLC1A2 mRNA CTD PMID:21782745 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of SLC1A2 mRNA CTD PMID:12873733 hydrogen peroxide multiple interactions ISO RGD:732300 6480464 Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein] CTD PMID:17138558 hydrogen peroxide decreases expression ISO RGD:732300 6480464 Hydrogen Peroxide results in decreased expression of SLC1A2 protein CTD PMID:17138558 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC1A2 mRNA CTD PMID:21396975 ivermectin decreases expression ISO RGD:732300 6480464 Ivermectin results in decreased expression of SLC1A2 protein CTD PMID:32959892 kainic acid multiple interactions ISO RGD:736773 6480464 [Kainic Acid co-treated with zinc chloride] results in decreased expression of SLC1A2 protein CTD PMID:19061913 kainic acid multiple interactions EXP 6480464 Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein] CTD PMID:28257918 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of SLC1A2 protein CTD PMID:28257918 ketamine increases expression EXP 6480464 Ketamine results in increased expression of SLC1A2 mRNA CTD PMID:20080153 KT 5720 multiple interactions EXP 6480464 KT 5720 inhibits the reaction [[1-(4-(6-bromobenzo(1 more ... CTD PMID:22645130 L-serine multiple interactions EXP 6480464 [LAMC1 protein modified form co-treated with ANGPT1 protein co-treated with Serine] inhibits the reaction [beta-N-methylamino-L-alanine results in decreased expression of SLC1A2 protein], Serine inhibits the reaction [beta-N-methylamino-L-alanine results in decreased expression of SLC1A2 protein] CTD PMID:30476904 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of SLC1A2 mRNA CTD PMID:15985313 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of SLC1A2 mRNA, Lead results in decreased expression of SLC1A2 protein CTD PMID:15955607 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of SLC1A2 mRNA, Lead results in decreased expression of SLC1A2 protein CTD PMID:15955607 linuron multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4 more ... CTD PMID:22645130 , PMID:24782323 manganese atom multiple interactions EXP 6480464 1-(4-(6-bromobenzo(1 more ... CTD PMID:22645130 , PMID:24469401 manganese atom multiple interactions ISO RGD:736773 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:28610743 manganese atom decreases expression ISO RGD:736773 6480464 Manganese results in decreased expression of SLC1A2 mRNA, Manganese results in decreased expression of SLC1A2 protein CTD PMID:28610743 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of SLC1A2 mRNA, Manganese results in decreased expression of SLC1A2 protein CTD PMID:22645130 , PMID:24469401 manganese(0) multiple interactions EXP 6480464 1-(4-(6-bromobenzo(1 more ... CTD PMID:22645130 , PMID:24469401 manganese(0) decreases expression ISO RGD:736773 6480464 Manganese results in decreased expression of SLC1A2 mRNA, Manganese results in decreased expression of SLC1A2 protein CTD PMID:28610743 manganese(0) multiple interactions ISO RGD:736773 6480464 Butyric Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:28610743 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of SLC1A2 mRNA, Manganese results in decreased expression of SLC1A2 protein CTD PMID:22645130 , PMID:24469401 manganese(II) chloride multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:19615351 , PMID:24782323 manganese(II) chloride multiple interactions ISO RGD:732300 6480464 Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA], Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 protein] CTD PMID:29778792 manganese(II) chloride decreases expression ISO RGD:732300 6480464 manganese chloride results in decreased expression of SLC1A2 mRNA, manganese chloride results in decreased expression of SLC1A2 protein CTD PMID:29778792 manganese(II) chloride decreases expression ISO RGD:736773 6480464 manganese chloride results in decreased expression of SLC1A2 mRNA, manganese chloride results in decreased expression of SLC1A2 protein CTD PMID:29183790 , PMID:29778792 manganese(II) chloride multiple interactions ISO RGD:736773 6480464 Estradiol inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:29183790 , PMID:29778792 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC1A2 mRNA, manganese chloride results in decreased expression of SLC1A2 protein CTD PMID:19615351 , PMID:24782323 mercury dibromide decreases expression ISO RGD:732300 6480464 mercuric bromide results in decreased expression of SLC1A2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:732300 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC1A2 mRNA CTD PMID:27188386 metacetamol decreases expression ISO RGD:736773 6480464 3-hydroxyacetanilide results in decreased expression of SLC1A2 mRNA CTD PMID:18544908 methamphetamine increases expression ISO RGD:736773 6480464 Methamphetamine results in increased expression of SLC1A2 mRNA CTD PMID:17105907 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of SLC1A2 mRNA CTD PMID:18419818 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC1A2 mRNA CTD PMID:30467583 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of SLC1A2 mRNA CTD PMID:21782745 methylmercury chloride increases expression ISO RGD:732300 6480464 methylmercuric chloride results in increased expression of SLC1A2 mRNA CTD PMID:23179753 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SLC1A2 mRNA CTD PMID:22966415 methylmercury chloride multiple interactions EXP 6480464 methylmercuric chloride results in decreased expression of and results in decreased activity of SLC1A2 protein more ... CTD PMID:22966415 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[1-(4-(6-bromobenzo(1 more ... CTD PMID:22645130 , PMID:24782323 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cobaltous chloride results in decreased expression of SLC1A2 protein], Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein] CTD PMID:19717140 , PMID:22895544 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of SLC1A2 mRNA CTD PMID:19716841 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 protein] CTD PMID:26988466 ochratoxin A affects expression EXP 6480464 ochratoxin A affects the expression of SLC1A2 protein CTD PMID:20558201 oxidopamine multiple interactions EXP 6480464 [Levodopa co-treated with Oxidopamine] results in increased expression of SLC1A2 mRNA CTD PMID:17329435 oxybenzone affects expression EXP 6480464 oxybenzone affects the expression of SLC1A2 protein CTD PMID:31368502 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of SLC1A2 mRNA CTD PMID:23439660 p-chloromercuribenzoic acid decreases expression ISO RGD:732300 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SLC1A2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:732300 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC1A2 mRNA CTD PMID:27188386 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of SLC1A2 mRNA CTD PMID:27638505 paclitaxel decreases expression EXP 6480464 Paclitaxel results in decreased expression of SLC1A2 protein CTD PMID:16361064 paracetamol affects expression ISO RGD:736773 6480464 Acetaminophen affects the expression of SLC1A2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC1A2 mRNA CTD PMID:30723492 paracetamol decreases expression ISO RGD:736773 6480464 Acetaminophen results in decreased expression of SLC1A2 mRNA CTD PMID:18544908 paraoxon increases expression EXP 6480464 Paraoxon results in increased expression of SLC1A2 mRNA, Paraoxon results in increased expression of SLC1A2 protein CTD PMID:27769869 paraoxon affects expression EXP 6480464 Paraoxon affects the expression of SLC1A2 mRNA, Paraoxon affects the expression of SLC1A2 protein CTD PMID:28603072 pentachlorophenol increases expression ISO RGD:736773 6480464 Pentachlorophenol results in increased expression of SLC1A2 mRNA CTD PMID:23892564 pentanal increases expression ISO RGD:732300 6480464 pentanal results in increased expression of SLC1A2 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC1A2 mRNA CTD PMID:27825932 phenformin increases expression EXP 6480464 Phenformin results in increased expression of SLC1A2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:736773 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC1A2 mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:736773 6480464 Phenobarbital results in decreased expression of SLC1A2 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:736773 6480464 Phenobarbital results in increased expression of SLC1A2 mRNA CTD PMID:19482888 phenylmercury acetate decreases expression ISO RGD:732300 6480464 Phenylmercuric Acetate results in decreased expression of SLC1A2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732300 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC1A2 mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:732300 6480464 picoxystrobin results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC1A2 mRNA CTD PMID:12832660 pirinixic acid decreases expression ISO RGD:736773 6480464 pirinixic acid results in decreased expression of SLC1A2 mRNA CTD PMID:20813756 , PMID:23811191 potassium dichromate affects expression ISO RGD:736773 6480464 Potassium Dichromate affects the expression of SLC1A2 mRNA CTD PMID:23608068 prochloraz multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 procymidone multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 propanal increases expression ISO RGD:732300 6480464 propionaldehyde results in increased expression of SLC1A2 mRNA CTD PMID:26079696 pyrimidifen decreases expression ISO RGD:732300 6480464 pyrimidifen results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [[1-(4-(6-bromobenzo(1 more ... CTD PMID:22645130 , PMID:24782323 pyrrolidine dithiocarbamate increases expression ISO RGD:736773 6480464 pyrrolidine dithiocarbamic acid results in increased expression of SLC1A2 protein CTD PMID:17409235 quercetin decreases expression ISO RGD:732300 6480464 Quercetin results in decreased expression of SLC1A2 mRNA CTD PMID:21632981 quinazolines multiple interactions EXP 6480464 Quinazolines inhibits the reaction [[1-(4-(6-bromobenzo(1 more ... CTD PMID:22645130 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of SLC1A2 mRNA, Raloxifene Hydrochloride results in increased expression of SLC1A2 protein CTD PMID:24782323 raloxifene multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Raloxifene Hydrochloride results in increased expression of SLC1A2 mRNA] more ... CTD PMID:24782323 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of SLC1A2 mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein] CTD PMID:25727173 rifampicin decreases expression ISO RGD:732300 6480464 Rifampin results in decreased expression of SLC1A2 mRNA CTD PMID:27199754 Riluzole multiple interactions EXP 6480464 Riluzole inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:19615351 , PMID:22966415 Riluzole increases expression EXP 6480464 Riluzole results in increased expression of SLC1A2 mRNA, Riluzole results in increased expression of SLC1A2 protein CTD PMID:22966415 romidepsin increases expression EXP 6480464 romidepsin results in increased expression of SLC1A2 mRNA CTD PMID:24469401 romidepsin multiple interactions EXP 6480464 romidepsin inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] CTD PMID:24469401 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC1A2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:732300 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite multiple interactions EXP 6480464 sodium arsenite results in decreased expression of and results in decreased activity of SLC1A2 protein CTD PMID:22020379 sodium arsenite decreases expression ISO RGD:736773 6480464 sodium arsenite results in decreased expression of SLC1A2 CTD PMID:29204679 Soman increases expression EXP 6480464 Soman results in increased expression of SLC1A2 mRNA CTD PMID:19281266 staurosporine multiple interactions EXP 6480464 Staurosporine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 protein] CTD PMID:26988466 tamoxifen decreases expression ISO RGD:736773 6480464 Tamoxifen results in decreased expression of SLC1A2 mRNA CTD PMID:25123088 tamoxifen multiple interactions ISO RGD:736773 6480464 Tamoxifen inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA], Tamoxifen inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 protein] CTD PMID:29183790 tebufenpyrad decreases expression ISO RGD:732300 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC1A2 mRNA, Carbon Tetrachloride results in decreased expression of SLC1A2 protein CTD PMID:12629582 more ... tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC1A2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:736773 6480464 Carbon Tetrachloride results in decreased expression of SLC1A2 mRNA CTD PMID:27339419 more ... thiamphenicol increases expression ISO RGD:736773 6480464 Thiamphenicol results in increased expression of SLC1A2 mRNA, Thiamphenicol results in increased expression of SLC1A2 protein CTD PMID:21945230 thiamphenicol increases expression ISO RGD:732300 6480464 Thiamphenicol results in increased expression of SLC1A2 mRNA CTD PMID:21945230 thifluzamide decreases expression ISO RGD:732300 6480464 thifluzamide results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 titanium dioxide multiple interactions ISO RGD:736773 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC1A2 mRNA CTD PMID:29950665 toluene affects expression EXP 6480464 Toluene affects the expression of SLC1A2 mRNA CTD PMID:18653662 trichloroethene decreases expression ISO RGD:736773 6480464 Trichloroethylene results in decreased expression of SLC1A2 mRNA CTD PMID:25549359 trichostatin A multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] CTD PMID:24469401 trichostatin A increases expression ISO RGD:732300 6480464 trichostatin A results in increased expression of SLC1A2 mRNA CTD PMID:19924110 , PMID:24935251 trichostatin A decreases expression ISO RGD:732300 6480464 trichostatin A results in decreased expression of SLC1A2 mRNA CTD PMID:24935251 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of SLC1A2 mRNA CTD PMID:24469401 triptonide increases expression ISO RGD:736773 6480464 triptonide results in increased expression of SLC1A2 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732300 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC1A2 mRNA CTD PMID:29024780 Tungsten carbide multiple interactions ISO RGD:732300 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of SLC1A2 mRNA CTD PMID:18078969 tyrphostin AG 1478 multiple interactions EXP 6480464 RTKI cpd inhibits the reaction [4 more ... CTD PMID:22645130 , PMID:24782323 valproic acid multiple interactions ISO RGD:732300 6480464 Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:19924110 , PMID:29778792 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of SLC1A2 mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC1A2 mRNA CTD PMID:29427782 valproic acid increases expression ISO RGD:732300 6480464 Valproic Acid results in increased expression of SLC1A2 mRNA, Valproic Acid results in increased expression of SLC1A2 protein CTD PMID:19924110 more ... valproic acid decreases methylation ISO RGD:732300 6480464 Valproic Acid results in decreased methylation of SLC1A2 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC1A2 mRNA CTD PMID:19924110 more ... valproic acid multiple interactions ISO RGD:736773 6480464 Valproic Acid inhibits the reaction [manganese chloride results in decreased expression of SLC1A2 mRNA] more ... CTD PMID:28610743 , PMID:29778792 valproic acid decreases expression ISO RGD:732300 6480464 Valproic Acid results in decreased expression of SLC1A2 mRNA CTD PMID:24383497 , PMID:28001369 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of SLC1A2 promoter CTD PMID:19924110 valproic acid multiple interactions EXP 6480464 [Valproic Acid results in decreased methylation of SLC1A2 promoter] which results in increased expression of SLC1A2 mRNA, Valproic Acid inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] CTD PMID:19924110 , PMID:24469401 vinclozolin multiple interactions EXP 6480464 [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 vorinostat multiple interactions EXP 6480464 vorinostat inhibits the reaction [Manganese results in decreased expression of SLC1A2 mRNA] CTD PMID:24469401 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of SLC1A2 mRNA CTD PMID:24469401 WIN 55212-2 increases expression EXP 6480464 (3R)-((2 more ... CTD PMID:17631920 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of SLC1A2 protein CTD PMID:18755231 zinc dichloride multiple interactions ISO RGD:736773 6480464 [Kainic Acid co-treated with zinc chloride] results in decreased expression of SLC1A2 protein CTD PMID:19061913 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of SLC1A2 protein CTD PMID:18755231
